Aveanna Healthcare (NASDAQ:AVAH) Insider Sells $135,804.36 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Edwin Reisz sold 16,602 shares of the firm’s stock in a transaction on Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total transaction of $135,804.36. Following the transaction, the insider directly owned 1,338,727 shares of the company’s stock, valued at approximately $10,950,786.86. This trade represents a 1.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Aveanna Healthcare Price Performance

NASDAQ:AVAH opened at $8.08 on Monday. The firm’s fifty day moving average is $8.92 and its two-hundred day moving average is $7.52. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $450.53 million during the quarter. Research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on AVAH shares. Truist Financial raised their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Raymond James Financial restated an “outperform” rating and set a $13.00 price target on shares of Aveanna Healthcare in a research report on Friday, December 5th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. William Blair started coverage on shares of Aveanna Healthcare in a research note on Monday, December 8th. They set an “outperform” rating on the stock. Finally, BMO Capital Markets assumed coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target for the company. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $10.69.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently modified their holdings of the stock. Jump Financial LLC acquired a new stake in shares of Aveanna Healthcare in the first quarter valued at about $59,000. Walleye Capital LLC lifted its stake in Aveanna Healthcare by 268.9% in the 1st quarter. Walleye Capital LLC now owns 51,470 shares of the company’s stock valued at $279,000 after buying an additional 37,517 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in Aveanna Healthcare by 16.2% in the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock worth $169,000 after buying an additional 4,349 shares during the last quarter. AQR Capital Management LLC increased its stake in Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after buying an additional 4,602 shares in the last quarter. Finally, Banque Transatlantique SA acquired a new position in shares of Aveanna Healthcare during the first quarter valued at approximately $25,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.